Dixon, John B.
Article History
First Online: 4 January 2016
Competing interests
: J.B.D. has received research funding and consultancy fees from Allergan and Nestlé Australia, and is a member of the Optifast<sup>®</sup> Medical Advisory Board of Nestlé Australia and the Medical Advisory Board of NovoNordisk. J.B.D. has also been a consultant for Apollo Endosurgery, Bariatric Advantage, mdBriefcase and Nestec, and received honoraria from Covidien, iNova Pharmaceuticals and Merck Sharp & Dohme.